Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Radiomic texture analysis based on neurite orientation dispersion and density imaging to differentiate glioblastoma from solitary brain metastasis

    We created discriminative models of different regions of interest (ROIs) using radiomic texture features of neurite orientation dispersion and density imaging (NODDI) and evaluated the feasibility of each mode...

    Jie Bai, Mengyang He, Eryuan Gao, Guang Yang, Hongxi Yang, Jie Dong in BMC Cancer (2023)

  2. Article

    Open Access

    Pre-operative clonal hematopoiesis is related to adverse outcome in lung cancer after adjuvant therapy

    Clonal hematopoiesis (CH) frequently progresses after chemotherapy or radiotherapy. We evaluated the clinical impact of preoperative CH on the survival outcomes of patients with non-small cell lung cancer (NSC...

    Jae Kwang Yun, Sugyeong Kim, Hongyul An, Geun Dong Lee, Hyeong Ryul Kim in Genome Medicine (2023)

  3. Article

    Open Access

    A differential diagnosis between uterine leiomyoma and leiomyosarcoma using transcriptome analysis

    The objective of this study was to estimate the accuracy of transcriptome-based classifier in differential diagnosis of uterine leiomyoma and leiomyosarcoma. We manually selected 114 normal uterine tissue and ...

    Kidong Kim, Sarah Kim, Tae** Ahn, Hyo** Kim, So-** Shin, Chel Hun Choi in BMC Cancer (2023)

  4. Article

    Open Access

    Effect of serum lactate dehydrogenase-to-albumin ratio (LAR) on the short-term outcomes and long-term prognosis of colorectal cancer after radical surgery

    Whether serum lactate dehydrogenase-to-albumin ratio (LAR) influenced the outcomes of colorectal cancer (CRC) patients after radical surgery remained unclear. Therefore, this study sought to examine how LAR in...

    **n-Peng Shu, Ying-Chun **ang, Fei Liu, Yong Cheng, Wei Zhang, Dong Peng in BMC Cancer (2023)

  5. Article

    Open Access

    MicroRNA 29a therapy for CEACAM6-expressing lung adenocarcinoma

    Non-coding microRNAs (miRNAs) play critical roles in tumor progression and hold great promise as therapeutic agents for multiple cancers. MicroRNA 29a (miR-29a) is a tumor suppressor miRNA that inhibits cancer...

    Seung-Myoung Son, Jieun Yun, Dong-Wook Kim, Young-Suk Jung, Sang-Bae Han in BMC Cancer (2023)

  6. Article

    Open Access

    Clinical implications of micro lymph node metastasis for patients with gastric cancer

    Lymph node size is considered as a criterion for possible lymph node metastasis in imageology. Micro lymph nodes are easily overlooked by surgeons and pathologists. This study investigated the influencing fact...

    Yuan Tian, Yue Pang, Pei-Gang Yang, Hong-Hai Guo, Yang Liu, Ze Zhang in BMC Cancer (2023)

  7. Article

    Open Access

    Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study

    Pathologic complete response (pCR) following preoperative systemic therapy is associated with improved outcomes after subsequent liver transplant/resection in hepatocellular carcinoma (HCC). However, the relat...

    Cheng Huang, **ao-Dong Zhu, Ying-Hao Shen, Bin Xu, Dong Wu, Yuan Ji in BMC Cancer (2023)

  8. Article

    Open Access

    miR-29b-3p suppresses the malignant biological behaviors of AML cells via inhibiting NF-κB and JAK/STAT signaling pathways by targeting HuR

    HuR/ELAVL1 (embryonic lethal abnormal vision 1) was a downstream target of miR-29b in some cancer cells. HuR protein exerts important prognostic effects of involving in the pathogenesis and development of acut...

    Yong-**g Tang, Wei Wu, Qiao-Qian Chen, Shu-Han Liu, Zhi-Yuan Zheng in BMC Cancer (2022)

  9. Article

    Open Access

    Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma

    To investigate the maximum tolerated dose (MTD) of apatinib delivered during and after intensity-modulated radiotherapy (IMRT) for unresectable hepatocellular carcinoma (HCC).

    Hongzhi Wang, **anggao Zhu, Yuting Zhao, Dezuo Dong, Lijuan Li, Yong Cai in BMC Cancer (2022)

  10. Article

    Open Access

    Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer

    Ferroptosis is an iron-dependent programmed cell death modality that may have a tumor-suppressive function. Therefore, regulating ferroptosis in tumor cells could serve as a novel therapeutic approach. This ar...

    Jian Hou, Zhenquan Lu, **aobao Cheng, Runan Dong, Yi Jiang, Guoqing Wu in BMC Cancer (2022)

  11. Article

    Open Access

    SYT-SSX1 enhances the invasiveness and maintains stem-like cell properties in synovial sarcoma via induction of TGF-β1/Smad signaling

    Synovial sarcoma (SS) is a type of soft tissue sarcoma (STS) of undetermined tissue origin, which is characterized by the recurrent pathognomonic chromosomal translocation t (X;18)(p11.2; q11.2). Studies have ...

    Yan Qi, Shuang-Shuang Dong, Yong-Lai He, Zi-Han Liu, Ya-Lan Huang, Ning Wang in BMC Cancer (2022)

  12. Article

    Open Access

    Dynamic survival analysis of gastrointestinal stromal tumors (GISTs): a 10-year follow-up based on conditional survival

    The prognosis of patients with gastrointestinal stromal tumors (GISTs) is generally evaluated at the time of diagnosis but does not reflect the survival dynamics of patients in the future. Therefore, the purpo...

    Shao-jun Xu, Si-yu Zhang, Ling-yi Dong, Guo-sheng Lin, Yong-jian Zhou in BMC Cancer (2021)

  13. Article

    Open Access

    Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma

    Pancreatic ductal adenocarcinoma (PDAC) remains a treatment-refractory malignancy with poor prognosis. It is urgent to identify novel and valid biomarkers to predict the progress and prognosis of PDAC. The S10...

    Hong-Bin Li, Jian-Li Wang, **ao-Dong **, Lei Zhao, Hui-Li Ye, Yan-bei Kuang in BMC Cancer (2021)

  14. Article

    Open Access

    Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics

    Mitochondrial fission regulator 2 (MTFR2) was involved in the progression and development of various cancers. However, the relationship between MTFR2 with lung adenocarcinoma (LUAD) had not been reported. Here...

    Cheng Chen, Yang Tang, Wen-Dong Qu, Xu Han, Jie-Bin Zuo, Qing-Yong Cai in BMC Cancer (2021)

  15. Article

    Open Access

    Tumor volume: a new prognostic factor of oncological outcome of localized clear cell renal cell carcinoma

    Clear cell renal cell carcinoma (ccRCC) is one of the most frequent malignancies; however, the present prognostic factors was deficient. This study aims to explore whether there is a relationship between tumor...

    Shao-Hao Chen, Long-Yao Xu, Yu-Peng Wu, Zhi-Bin Ke, Peng Huang, Fei Lin in BMC Cancer (2021)

  16. Article

    Open Access

    Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles

    To determine if extended chemotherapy improves survival outcomes in patients with platinum-sensitive relapsed epithelial ovarian cancer (EOC) who have residual disease after six cycles of second-line chemother...

    Se Ik Kim, Woo Yeon Hwang, Maria Lee, Hee Seung Kim, Kidong Kim in BMC Cancer (2020)

  17. Article

    Open Access

    Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis

    Recent evidence suggests that albumin-to-Alkaline Phosphatase Ratio (AAPR) functions as a novel prognostic marker in several malignancies. However, whether it can predict the prognosis of unresectable pancreat...

    Ke Zhang, Shu Dong, Yan-Hua **g, Hui-Feng Gao, Lian-Yu Chen, Yong-Qiang Hua in BMC Cancer (2020)

  18. Article

    Open Access

    CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial

    Cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP)/CHOP-like chemotherapy is widely used in peripheral T cell lymphoma (PTCL). Here we conducted a phase 2, multicenter, randomized, controlled ...

    Ming-Ci Cai, Shu Cheng, **n Wang, Jian-Da Hu, Yong-** Song in Genome Medicine (2020)

  19. Article

    Open Access

    Identification of microRNAs and their Endonucleolytic Cleavaged target mRNAs in colorectal cancer

    Colorectal cancer (CRC) ranks the third among the most common malignancies globally. It is well known that microRNAs (miRNAs) play vital roles in destabilizing mRNAs and repressing their translations in this d...

    Fangbin Zhou, Donge Tang, Yong Xu, Huiyan He, Yan Wu, Liewen Lin, Jun Dong in BMC Cancer (2020)

  20. Article

    Open Access

    Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma

    The upregulated expression of the JAK/STAT pathway promotes tumor growth in Hodgkin lymphoma (HL) and primary mediastinal large B-cell lymphoma (PMBCL). Based on the hypothesis that JAK2 is a therapeutic targe...

    Seok ** Kim, Dok Hyun Yoon, Hye ** Kang, Jung Yong Hong, Ho Sup Lee in BMC Cancer (2019)

previous disabled Page of 3